IP Verse

Furo Ventures B.v. competitive analysis

Explore patent oppositions filed by Furo Ventures B.v. against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 3, 2026

Patent Number	Title	Applicant	Opposition Date
EP2376535	Anti-Pd-L1 Antibodies And Their Use To Enhance T-Cell Function	F HOFFMANN LA ROCHE	Jan 12, 2018
EP2358756	High Affinity Human Antibodies To Pcsk9	REGENERON PHARMACEUTICALS	Oct 11, 2017
EP2295126	Method For Purification Of Alpha-1-Antitrypsin	CSL BEHRING	Sep 15, 2016
EP2066352	Treatment Of Multiple Sclerosis (Ms) With Campath-1H	ALCAFLEU MANAGEMENT	Sep 2, 2016
EP2777689	New Pharmaceutical Composition For The Treatment Of Fungal Infections	MOBERG PHARMA	Feb 29, 2016
EP2735562	Estrogen Receptor Modulators And Uses Thereof	SERAGON PHARMACEUTICALS	Dec 11, 2015
EP2613798	Use Of Lysosomal Acid Lipase For Treating Lysosomal Acid Lipase Deficiency In Patients	SYNAGEVA BIOPHARMA	Nov 10, 2015

Discover the latest PTAB cases involving Furo Ventures B.v., highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Furo Ventures B.v. with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 3, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
FURO VENTURES B.V.	7	-	-	-
ALCAFLEU MANAGEMENT	-	1	-	-
BAYER	42	136	-	-
CSL BEHRING	-	12	4	-